% alzhub.org library filter
% Source: https://alzhub.org/research?author=Janelidze+S&score_min=70
% 27 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{warmenhoven2025-39468767,
  author  = {Warmenhoven, N. and Salvadó, G. and Janelidze, S. and Mattsson-Carlgren, N. and Bali, D. and Orduña Dolado, A. and Kolb, H. and Triana-Baltzer, G. and Barthélemy, N. R. and Schindler, S. E. and Aschenbrenner, A. J. and Raji, C. A. and others},
  title   = {{A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests}},
  journal = {Brain},
  year    = {2025},
  doi     = {10.1093/brain/awae346},
  pmid    = {39468767},
  url     = {https://doi.org/10.1093/brain/awae346}
}

@article{ossenkoppele2025-40155777,
  author  = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others},
  title   = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}},
  journal = {Nature Aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00835-z},
  pmid    = {40155777},
  url     = {https://doi.org/10.1038/s43587-025-00835-z}
}

@article{karikari2020-32333900,
  author  = {Karikari, T. K. and Pascoal, T. A. and Ashton, N. J. and Janelidze, S. and Benedet, A. L. and Rodriguez, J. L. and Chamoun, M. and Savard, M. and others},
  title   = {{Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts}},
  journal = {The Lancet. Neurology},
  year    = {2020},
  doi     = {10.1016/s1474-4422(20)30071-5},
  pmid    = {32333900},
  url     = {https://doi.org/10.1016/s1474-4422(20)30071-5}
}

@article{pereira2021-34259835,
  author  = {Pereira, J. B. and Janelidze, S. and Smith, R. and Mattsson-Carlgren, N. and Palmqvist, S. and Teunissen, C. E. and Zetterberg, H. and Stomrud, E. and others},
  title   = {{Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awab223},
  pmid    = {34259835},
  url     = {https://doi.org/10.1093/brain/awab223}
}

@article{brum2023-37653254,
  author  = {Brum, W. S. and Cullen, N. C. and Janelidze, S. and Ashton, N. J. and Zimmer, E. R. and Therriault, J. and Benedet, A. L. and Rahmouni, N. and Tissot, C. and Stevenson, J. and Servaes, S. and Triana-Baltzer, G. and others},
  title   = {{A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases}},
  journal = {Nature Aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00471-5},
  pmid    = {37653254},
  url     = {https://doi.org/10.1038/s43587-023-00471-5}
}

@article{palmqvist2020-32722745,
  author  = {Palmqvist, S. and Janelidze, S. and Quiroz, Y. T. and Zetterberg, H. and Lopera, F. and Stomrud, E. and Su, Y. and Chen, Y. and others},
  title   = {{Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders}},
  journal = {JAMA},
  year    = {2020},
  doi     = {10.1001/jama.2020.12134},
  pmid    = {32722745},
  url     = {https://doi.org/10.1001/jama.2020.12134}
}

@article{janelidze2024-39068669,
  author  = {Janelidze, S. and Barthélemy, N. R. and Salvadó, G. and Schindler, S. E. and Palmqvist, S. and Mattsson-Carlgren, N. and Braunstein, J. B. and Ovod, V. and Bollinger, J. G. and He, Y. and Li, Y. and Raji, C. A. and others},
  title   = {{Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment}},
  journal = {JAMA Neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.2619},
  pmid    = {39068669},
  url     = {https://doi.org/10.1001/jamaneurol.2024.2619}
}

@article{raket2026-41178353,
  author  = {Raket, L. L. and Binette, A. P. and Mattsson-Carlgren, N. and Janelidze, S. and Zetterberg, H. and Ashton, N. J. and Blennow, K. and Stomrud, E. and others},
  title   = {{Estimating the time course of biomarker changes in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2026},
  doi     = {10.1093/brain/awaf413},
  pmid    = {41178353},
  url     = {https://doi.org/10.1093/brain/awaf413}
}

@article{janelidze2021-33165506,
  author  = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others},
  title   = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2020.4201},
  pmid    = {33165506},
  url     = {https://doi.org/10.1001/jamaneurol.2020.4201}
}

@article{janelidze2020-32123385,
  author  = {Janelidze, S. and Mattsson, N. and Palmqvist, S. and Smith, R. and Beach, T. G. and Serrano, G. E. and Chai, X. and Proctor, N. K. and others},
  title   = {{Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia}},
  journal = {Nature medicine},
  year    = {2020},
  doi     = {10.1038/s41591-020-0755-1},
  pmid    = {32123385},
  url     = {https://doi.org/10.1038/s41591-020-0755-1}
}

@article{janelidze2020-32246036,
  author  = {Janelidze, S. and Stomrud, E. and Smith, R. and Palmqvist, S. and Mattsson, N. and Airey, D. C. and Proctor, N. K. and Chai, X. and others},
  title   = {{Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-020-15436-0},
  pmid    = {32246036},
  url     = {https://doi.org/10.1038/s41467-020-15436-0}
}

@article{mattssoncarlgren2020-33068398,
  author  = {Mattsson-Carlgren, N. and Janelidze, S. and Palmqvist, S. and Cullen, N. and Svenningsson, A. L. and Strandberg, O. and Mengel, D. and Walsh, D. M. and others},
  title   = {{Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa286},
  pmid    = {33068398},
  url     = {https://doi.org/10.1093/brain/awaa286}
}

@article{barthelemy2024-38382645,
  author  = {Barthélemy, N. R. and Salvadó, G. and Schindler, S. E. and He, Y. and Janelidze, S. and Collij, L. E. and Saef, B. and Henson, R. L. and others},
  title   = {{Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02869-z},
  pmid    = {38382645},
  url     = {https://doi.org/10.1038/s41591-024-02869-z}
}

@article{mattsson2016-27694257,
  author  = {Mattsson, N. and Zetterberg, H. and Janelidze, S. and Insel, P. S. and Andreasson, U. and Stomrud, E. and Palmqvist, S. and Baker, D. and others},
  title   = {{Plasma tau in Alzheimer disease}},
  journal = {Neurology},
  year    = {2016},
  doi     = {10.1212/wnl.0000000000003246},
  pmid    = {27694257},
  url     = {https://doi.org/10.1212/wnl.0000000000003246}
}

@article{therriault2024-39533113,
  author  = {Therriault, J. and Janelidze, S. and Benedet, A. L. and Ashton, N. J. and Arranz Martínez, J. and Gonzalez-Escalante, A. and Bellaver, B. and Alcolea, D. and others},
  title   = {{Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability}},
  journal = {Nature aging},
  year    = {2024},
  doi     = {10.1038/s43587-024-00731-y},
  pmid    = {39533113},
  url     = {https://doi.org/10.1038/s43587-024-00731-y}
}

@article{janelidze2018-30054439,
  author  = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.},
  title   = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000006082},
  pmid    = {30054439},
  url     = {https://doi.org/10.1212/wnl.0000000000006082}
}

@article{salvado2025-40952756,
  author  = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others},
  title   = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3217},
  pmid    = {40952756},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3217}
}

@article{leuzy2022-34928318,
  author  = {Leuzy, A. and Smith, R. and Cullen, N. C. and Strandberg, O. and Vogel, J. W. and Binette, A. P. and Borroni, E. and Janelidze, S. and others},
  title   = {{Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4654},
  pmid    = {34928318},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4654}
}

@article{janelidze2023-36087307,
  author  = {Janelidze, S. and Bali, D. and Ashton, N. J. and Barthélemy, N. R. and Vanbrabant, J. and Stoops, E. and Vanmechelen, E. and others},
  title   = {{Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac333},
  pmid    = {36087307},
  url     = {https://doi.org/10.1093/brain/awac333}
}

@article{janelidze2021-34542571,
  author  = {Janelidze, S. and Teunissen, C. E. and Zetterberg, H. and Allué, J. A. and Sarasa, L. and Eichenlaub, U. and Bittner, T. and Ovod, V. and others},
  title   = {{Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.3180},
  pmid    = {34542571},
  url     = {https://doi.org/10.1001/jamaneurol.2021.3180}
}

@article{nilsson2024-38325331,
  author  = {Nilsson, J. and Pichet Binette, A. and Palmqvist, S. and Brum, W. S. and Janelidze, S. and Ashton, N. J. and Spotorno, N. and Stomrud, E. and others},
  title   = {{Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases}},
  journal = {Brain : a journal of neurology},
  year    = {2024},
  doi     = {10.1093/brain/awae032},
  pmid    = {38325331},
  url     = {https://doi.org/10.1093/brain/awae032}
}

@article{cicognola2025-39817469,
  author  = {Cicognola, C. and Salvadó, G. and Smith, R. and Palmqvist, S. and Stomrud, E. and Betthauser, T. J. and Johnson, S. C. and Janelidze, S. and others},
  title   = {{APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β}},
  journal = {Brain : a journal of neurology},
  year    = {2025},
  doi     = {10.1093/brain/awaf016},
  pmid    = {39817469},
  url     = {https://doi.org/10.1093/brain/awaf016}
}

@article{janelidze2025-40541209,
  author  = {Janelidze, S. and Collij, L. E. and Mattsson-Carlgren, N. and Antill, A. and Laymon, C. M. and Lott, I. and Rosas, H. D. and Minhas, D. S. and others},
  title   = {{Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study}},
  journal = {The Lancet. Neurology},
  year    = {2025},
  doi     = {10.1016/s1474-4422(25)00158-9},
  pmid    = {40541209},
  url     = {https://doi.org/10.1016/s1474-4422(25)00158-9}
}

@article{palmqvist2019-31233127,
  author  = {Palmqvist, S. and Janelidze, S. and Stomrud, E. and Zetterberg, H. and Karl, J. and Zink, K. and Bittner, T. and Mattsson, N. and others},
  title   = {{Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1632},
  pmid    = {31233127},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1632}
}

@article{ashton2021-34099648,
  author  = {Ashton, N. J. and Janelidze, S. and Al Khleifat, A. and Leuzy, A. and van der Ende, E. L. and Karikari, T. K. and Benedet, A. L. and Pascoal, T. A. and others},
  title   = {{A multicentre validation study of the diagnostic value of plasma neurofilament light}},
  journal = {Nature communications},
  year    = {2021},
  doi     = {10.1038/s41467-021-23620-z},
  pmid    = {34099648},
  url     = {https://doi.org/10.1038/s41467-021-23620-z}
}

@article{jonaitis2023-37013174,
  author  = {Jonaitis, E. M. and Janelidze, S. and Cody, K. A. and Langhough, R. and Du, L. and Chin, N. A. and Mattsson-Carlgren, N. and Hogan, K. J. and others},
  title   = {{Plasma phosphorylated tau 217 in preclinical Alzheimer's disease}},
  journal = {Brain communications},
  year    = {2023},
  doi     = {10.1093/braincomms/fcad057},
  pmid    = {37013174},
  url     = {https://doi.org/10.1093/braincomms/fcad057}
}

@article{pereira2021-34077494,
  author  = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awab163},
  pmid    = {34077494},
  url     = {https://doi.org/10.1093/brain/awab163}
}